Concepedia

Mengye Peng

MP

Statistics

Publications

4

Citations

287

H-Index

4

Active since

2007

Affiliations

Harbin Medical University(Current)

Third Affiliated Hospital of Harbin Medical University

Nanjing General Hospital of Nanjing Military Command

Soochow University

Tongji Hospital

Mengye Peng is an author at Harbin Medical University specializing in medicine, oncology, and neoplasia.

Publications per year

2007–2022

4

Publications

4

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

Jianming Xu, Lin Shen, Zhiwei Zhou et al. · The Lancet Oncology · 2020 · 190 citations

, , +8

Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study

Huafang Li, Cui Ma, Gang Wang et al. · Current Medical Research and Opinion · 2007 · 54 citations

, , +13

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer

Liping Yang, Xitao He, Mengye Peng et al. · Frontiers in Oncology · 2022 · 22 citations · Full text

, , +17

A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study

Shun Lü, Gongyan Chen, Yuping Sun et al. · Lung Cancer · 2020 · 21 citations

, , +7

1–4 of 4